TREATMENT OF METASTATIC GERM-CELL TUMORS IN MEN WITH ADRIAMYCIN, VINCRISTINE, AND BLEOMYCIN
- 1 January 1977
- journal article
- research article
- Vol. 61 (8), 1447-1451
Abstract
Patients (25) with metastatic germ-cell tumors were treated with a combination of adriamycin, vincristine and bleomycin. Fifteen patients (60%) previously received radiation therapy, chemotherapy, or both. Twenty patients (80%) responded to treatment, with 8 (32%) patients achieving a complete remission (CR) and 12(48%) patients achieving a partial remission (PR). The median duration of response for the patients with PR was 4 mo., whereas 4 patients with a CR remain alive without evidence of disease for > 3 yr after the initiation of treatment. Responses were observed in all tumor categories and apparently were not influenced by prior therapy. Side effects included gastrointestinal toxicity, alopecia, neuropathy, skin changes, mucositis and myelosuppression (more severe in previously treated patients). Though moderate success was demonstrated for this chemotherapy regimen, it does not appear as effective as more recent regimens including vinblastine and bleomycin.This publication has 7 references indexed in Scilit:
- Improved Chemotherapy in Disseminated Testicular CancerJournal of Urology, 1977
- Chemotherapy of germ cell tumors of the testis. I. Induction of remissions with vinblastine, actinomycin D, and bleomycinCancer, 1976
- EVALUATION OF BLEOMYCIN, ADRIAMYCIN, AND VINBLASTINE IN COMBINATION THERAPY FOR ADVANCED TESTICULAR TUMORS1976
- AdriamycinAnnals of Internal Medicine, 1974
- Chemotherapy of metastatic testis cancer:Results in 154 patientsCancer, 1966
- INITIAL CLINICAL STUDIES WITH VINCRISTINE1962
- Testicular tumors. A clinicopathological studyCancer, 1953